MYGN MYRIAD GENETICS INC

Did the company actually spend money buying back stock in 3+ of the last 4 quarters?

Bought back stock in only 1/4 quarters. Q3 2019: $0M, Q3 2020: $0M, Q3 2018: $0M, Q2 2018: $10M

Is the most recent quarter's buyback spend more than 15% above the trailing average?

Latest quarter $0M vs trailing avg $3M (-100%)

What percentage of free cash flow is going to buybacks? Bull: 30-80%. Bear: <10% or >80%.

Negative FCF ($-79M), cannot compute buyback ratio

How fast are they shrinking the float? Bull: 2%+ annually. Bear: under 0.5%.

Repurchased 0 shares = 0.0% of 89,900,000 outstanding (annualized)

Are officers and directors buying stock with their own money on the open market?

4 open-market purchases by 2 insiders

• Raha Samraat S. (President and CEO) bought 40,000 shares at $5.00 on 2026-03-09
• Phanstiel S. Louise () bought 48,000 shares at $4.66 on 2026-02-27
• Phanstiel S. Louise () bought 50,407 shares at $4.80 on 2026-02-26
• Phanstiel S. Louise () bought 6,100 shares at $4.74 on 2026-02-25

Are insider purchases happening during the same quarters the company is actively buying back stock?

Insider buying coincided with company buybacks in 0 of 4 quarters

Looking at all open-market transactions, are insiders net buyers or net sellers?

Insiders bought $1M, sold $0M (net buying)

Active buyback + insiders net selling 3x+ more than buying. Company cash may be supporting price while insiders exit.

No buyback-insider divergence detected